Annie De Groot

Has grant

Senior Scientist and Professor

University of Georgia

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

ISPRI-HCP: CHO protein impurity immunogenicity risk prediction for improving biosimilar product development and assessing product interchangeability

Open Date: 2022-09-01

Close Date: 2024-08-31

Grant: Close

Influenza vaccine immunity shaped by human-like influenza epitopes

Open Date: 2018-08-02

Close Date: 2020-07-31

Grant: Close

GAA-ITEM: Personalizing the Prediction of Anti-therapeutic Antibody Response in Pompe Disease Patients

Open Date: 2018-05-09

Close Date: 2020-04-30

Grant: Close

Novel Antigen-Specific Immunomodulatory Tregitope-based Therapy to Address Autoimmune Pathogenesis in Graves' Disease

Open Date: 2017-09-01

Close Date: 2019-08-31

Grant: Close

Novel Antigen-Specific Immunomodulatory Tregitope-based Therapy to Address Autoimmune Pathogenesis in Graves' Disease

Open Date: 2017-09-01

Close Date: 2020-02-29

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Lenny Moise

Research Professor

University of Georgia

UNITED STATES

View details

Ted Ross

Director and Professor of Infectious Diseases

University of Georgia

UNITED STATES

View details

Patrick Reeves

Assistant Professor

Harvard Medical School

UNITED STATES

View details

Justin Bahl

University of Georgia

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Annie De Groot

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Specific sequence mutations in a long-lasting rhIFN-α2b version reduce in vitro and in vivo immunogenicity and increase in vitro protein stability

Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice

Expanding access to COVID-19 testing, vaccination and treatment at a free clinic for uninsured Spanish-speaking adults in Providence, RI.

H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans.

Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of <i>Coxiella burnetii</i> Immunity.

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy

Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases.

Identification and Immune Assessment of T Cell Epitopes in Five <i>Plasmodium falciparum</i> Blood Stage Antigens to Facilitate Vaccine Candidate Selection and Optimization.

Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse <i>Plasmodium falciparum</i> Strains.

Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach.

Collaborators (4)

Lenny Moise

Ted Ross

Patrick Reeves

Justin Bahl

Make your next move.